Baseline characteristics
| Number of patients/ median | Percentage/ IQR | |
| Male gender | 10 | 41.7 |
| Age in years, median | 59.0 | 22.5–74.7 |
| Aetiology of portal hypertension | ||
| Primary sclerosing cholangitis (PSC) | 9 | 37.5 |
| Alcoholic cirrhosis | 6 | 25.0 |
| Non-alcoholic fatty liver disease | 4 | 16.7 |
| Portal vein thrombosis (secondary to ITP) | 1 | 4.2 |
| PSC and portal vein stenosis | 1 | 4.2 |
| Primary biliary cholangitis | 1 | 4.2 |
| Liver metastasis | 1 | 4.2 |
| Hepatitis C cirrhosis | 1 | 4.2 |
| Child-Pugh Class | ||
| A | 14 | 58.3 |
| B | 7 | 29.2 |
| C | 3 | 12.5 |
| Model for End-stage Liver Disease Score, median | 12 | 10–17 |
| Previous esophagogastric variceal haemorrhage | 0 | 0 |
| Previous treatment for varices | ||
| Beta-blocker | 17 | 70.8 |
| Oesophageal variceal band ligation | 3 | 12.5 |
| Transjugular intrahepatic portosystemic stent shunt | 2 | 8.3 |
| None | 5 | 20.8 |
| Type of stoma | ||
| Ileostomy | 19 | 79.2 |
| Colostomy | 4 | 16.7 |
| Urostomy | 1 | 4.2 |
| Indication for stoma | ||
| Inflammatory bowel disease | 17 | 70.8 |
| Colorectal cancer | 5 | 20.8 |
| Previous bowel perforation | 1 | 4.2 |
| Cystectomy for tuberculosis | 1 | 4.2 |
| Years since stoma formation, median | 5.4 | 2.9–21.6 |
Data presented as number of patients with percentage, or median and IQR as specified.
ITP, Immune Thrombocytopaenia.